NEW YORK (GenomeWeb News) - Millipore yesterday said third-quarter revenues increased 12 percent as R&D spending swelled 8 percent and profit shot up nearly 150 percent.

 

Total receipts for the three months ended Sept. 29 increased to $371.2 million from $330.1 million year over year.

 

Sales in the company's Bioprocess segment rose 8 percent to $210.5 million, while Bioscience revenue rose 19 percent to $160.7 million.